Grunnleggende statistikk
| CIK | 913077 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Affymetrix, Inc.
SEC Filings (Chronological Order)
På denne siden finner du en fullstendig, kronologisk liste over SEC-arkiveringer, med unntak av eierskaps-arkiveringer som vi leverer andre steder.
| February 13, 2017 |
AFFX / Affymetrix, Inc. / ORBIMED ADVISORS LLC - 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 1, 2017 |
AFFX / Affymetrix, Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Affymetrix Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| April 15, 2016 |
15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-28218 AFFYMETRIX, INC. (Exact name of registrant as specified in |
|
| April 1, 2016 |
15-15D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Numbers: 333-181781, 333-112311 AFFYMETRIX, INC. (Exact name of registrant as |
|
| April 1, 2016 |
15-15D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Numbers: 333-181781, 333-112311 AFFYMETRIX, INC. (Exact name of registrant as |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS 1 d156753ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. 333-11299 Form S-8 Registration No. 333-35287 Form S-8 Registration No. 333-85575 Form S-8 Registration No. 333-34320 Form S-8 Registration No. 333-52804 Form S-8 Registration No. 333-59158 Form S-8 Registration No. 333-59160 Form S-8 Registration No. 333-123452 Form |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
S-8 POS As filed with the Securities and Exchange Commission on April 1, 2016 Form S-8 Registration No. |
|
| April 1, 2016 |
POS AM 1 d127268dposam.htm POS AM As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. 333-51914 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-3 UNDER THE SECURITIES ACT OF 1933 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0319159 (State or Other Jurisdiction |
|
| April 1, 2016 |
As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. |
|
| April 1, 2016 |
POS AM As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. |
|
| April 1, 2016 |
As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. |
|
| April 1, 2016 |
POS AM As filed with the Securities and Exchange Commission on April 1, 2016 Registration No. |
|
| March 31, 2016 |
EX-3.1 2 d162991dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AFFYMETRIX, INC., A DELAWARE CORPORATION * * * * * * * ARTICLE I The name of the corporation is: Affymetrix, Inc. ARTICLE II The address of the Corporation’s registered office in the State of Delaware is 1675 South State Street, Suite B, City of Dover, County of Kent 19901. The name of the Corporation |
|
| March 31, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 31, 2016 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organizati |
|
| March 31, 2016 |
EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Thermo Fisher media contact: Karen Kirkwood Thermo Fisher investor contact: Ken Apicerno Phone: 781-622-1306 Phone: 781-622-1294 E-mail: [email protected] E-mail: [email protected] Website: www.thermofisher.com Affymetrix media contact: Mindy Lee-Olsen Phone: 408-731-5523 E-mail: [email protected] Affymetrix investor |
|
| March 31, 2016 |
EX-4.1 Exhibit 4.1 AFFYMETRIX, INC., AS ISSUER and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE Second Supplemental Indenture Dated as of March 31, 2016 to the Indenture Dated as of June 25, 2012 SECOND SUPPLEMENTAL INDENTURE This SECOND SUPPLEMENTAL INDENTURE (this ?Second Supplemental Indenture?), dated as of March 31, 2016, is by and between Affymetrix, Inc., a Delaware corporati |
|
| March 31, 2016 |
AMENDED AND RESTATED BY-LAWS AFFYMETRIX, INC. A Delaware Corporation ARTICLE I – GENERAL EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF AFFYMETRIX, INC. A Delaware Corporation ARTICLE I GENERAL Section 1.1. Offices. The registered office of Affymetrix, Inc. (the Corporation) in the State of Delaware shall be located at 1675 South State Street, Suite B, City of Dover, County of Kent. The name of the Corporations registered agent at such address shall be Capitol Services, Inc. |
|
| March 29, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Pro |
|
| March 29, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 28, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| March 28, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| March 24, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Pro |
|
| March 23, 2016 |
DEFA14A 1 d167495ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 23, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| March 23, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| March 22, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Pro |
|
| March 22, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 21, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 21, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 21, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| March 21, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Pro |
|
| March 18, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 16, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 15, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 10, 2016 |
DEFA14A 1 d149330ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| March 1, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| February 24, 2016 |
DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 18, 2016 |
AFFYMETRIX, INC. LIST OF SUBSIDIARIES EXHIBIT 21 AFFYMETRIX, INC. LIST OF SUBSIDIARIES Affymetrix Biotech Ltda., a wholly-owned subsidiary incorporated in Brazil and doing business under such name. Affymetrix Biotech Shanghai Ltd., a wholly-owned subsidiary incorporated in China and doing business under such name. Affymetrix Japan K.K., a wholly-owned subsidiary incorporated in Japan and doing business under such name. Affymetrix Pte |
|
| February 18, 2016 |
Affymetrix 10-K (Annual Report) 10-K 1 affx1231201510-k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE |
|
| February 17, 2016 |
Affymetrix 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2016 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employ |
|
| February 17, 2016 |
AFFYMETRIX REPORTS FOURTH QUARTER 2015 OPERATING RESULTS EX-99.1 2 affx-20151231ex99x1.htm EXHIBIT 99.1 EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FOURTH QUARTER 2015 OPERATING RESULTS Santa Clara, Calif.—February 17, 2016—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the fourth quarter of 2015. Results for the year ended December 31, 2015: • Total revenue was $359. |
|
| February 16, 2016 |
AFFX / Affymetrix, Inc. / CITADEL ADVISORS LLC - FORM SC 13G/A Passive Investment SC 13G/A 1 v429574sc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Affymetrix, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 00826T108 (CUSIP Number) December |
|
| February 12, 2016 |
PRER14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 12, 2016 |
Affymetrix SCHEDULE 13G/A (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 12, 2016 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment SC 13G/A 1 a16-40585sc13ga.htm SC 13G/A UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D.C. 20549 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . .10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* Affymetrix Inc (Name of Issuer) Common (Title of Class of Securities) 00826T108 (CUSIP Nu |
|
| February 11, 2016 |
AFFX / Affymetrix, Inc. / M&G INVESTMENT MANAGEMENT LTD - AFFYMETRIX INC. Passive Investment Affymetrix Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Affymetrix Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) 31st December 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| February 10, 2016 |
Invesco Joint Filing Agreement JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd. |
|
| February 10, 2016 |
AFFX / Affymetrix, Inc. / VANGUARD GROUP INC Passive Investment affymetrixinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Affymetrix Inc Title of Class of Securities: Common Stock CUSIP Number: 00826T108 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to desi |
|
| February 10, 2016 |
AFFX / Affymetrix, Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Affymetrix Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 3, 2016 |
Preliminary Proxy Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 15, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 14, 2016 |
Affymetrix FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 8, 2016 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organizat |
|
| January 14, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 8, 2016 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organizat |
|
| January 14, 2016 |
EX-2.1 2 d100504dex21.htm EX-2.1 Exhibit 2.1 The Merger Agreement has been included to provide stockholders with information regarding its terms. It is not intended to provide any other factual information about Affymetrix or Thermo Fisher. The Merger Agreement contains representations and warranties that the parties to the Merger Agreement made to and solely for the benefit of each other and only |
|
| January 14, 2016 |
EX-2.1 2 d100504dex21.htm EX-2.1 Exhibit 2.1 The Merger Agreement has been included to provide stockholders with information regarding its terms. It is not intended to provide any other factual information about Affymetrix or Thermo Fisher. The Merger Agreement contains representations and warranties that the parties to the Merger Agreement made to and solely for the benefit of each other and only |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
DEFA14A 1 d100802ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
DEFA14A 1 d117358d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 8, 2016 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of I |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
THERMO FISHER SCIENTIFIC TO ACQUIRE AFFYMETRIX EX-99.1 2 d117358dex991.htm EX-99.1 Exhibit 99.1 News FOR IMMEDIATE RELEASE Thermo Fisher Media Contact Information: Karen Kirkwood Thermo Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1306 Phone: 781-622-1294 E-mail: [email protected] E-mail: [email protected] Website: www.thermofisher.com Affymetrix Media Contact Information: Mindy Lee-Olsen Phone: 40 |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
Affymetrix FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 8, 2016 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organizat |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| January 11, 2016 |
THERMO FISHER SCIENTIFIC TO ACQUIRE AFFYMETRIX EX-99.1 2 d117358dex991.htm EX-99.1 Exhibit 99.1 News FOR IMMEDIATE RELEASE Thermo Fisher Media Contact Information: Karen Kirkwood Thermo Fisher Investor Contact Information: Ken Apicerno Phone: 781-622-1306 Phone: 781-622-1294 E-mail: [email protected] E-mail: [email protected] Website: www.thermofisher.com Affymetrix Media Contact Information: Mindy Lee-Olsen Phone: 40 |
|
| November 10, 2015 |
CHANGE OF CONTROL PLAN EFFECTIVE JANUARY 1, 2016 Exhibit 10.1 CHANGE OF CONTROL PLAN EFFECTIVE JANUARY 1, 2016 1. Introduction. The purpose of the Affymetrix, Inc. Change of Control Plan (the ?Plan?) is to provide severance benefits to eligible employees of Affymetrix, Inc. and its subsidiaries (the ?Company?) when there has been a ?change of control? of the Company followed by the eligible employee?s termination of employment under specified ci |
|
| November 10, 2015 |
EXECUTIVE SEVERANCE POLICY (Amended and Effective as of November 5, 2015) Exhibit 10.2 EXECUTIVE SEVERANCE POLICY (Amended and Effective as of November 5, 2015) I. PURPOSE AND ELIGIBILITY Affymetrix Inc. (the ?Company?) has adopted this Executive Severance Policy (?Policy?) to provide guidelines for the granting of severance pay and/or certain other benefits (as set forth in Section III.B below, ?Severance Pay?) under specified circumstances to employees of the Company |
|
| November 10, 2015 |
Affymetrix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT pursuant to Section 13 or 15(D) of the Securities and Exchange Act of 1934 Date of report: November 5, 2015 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| October 29, 2015 |
SCHEDULE 1 RATE SCHEDULE SINGAPORE DOLLARS ADDENDUM TO LEASE AGREEMENT SIGNED DATED 13 FEBRUARY 2006 This Addendum No: 2015/1029 is made on the 23 September 2015 between KEPPEL LOGISTICS PTE LTD, a Company incorporated under the laws of Singapore having its registered office at 1 Harbour Front Avenue, #18-01 Keppel Bay Tower, Singapore 098632 (hereinafter called “the Lessor”) and AFFYMETRIX PTE LTD, a Company incorporated under the laws of Singapore having its principal place of business at No. |
|
| October 29, 2015 |
Exhibit 10.1 CREDIT AGREEMENT Dated as of October 28, 2015 among AFFYMETRIX, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and THE LENDERS PARTY HERETO MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, as Sole Lead Arranger and Sole Bookrunner TABLE OF CONTENTS Page ART |
|
| October 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 affx-20150930x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COM |
|
| October 29, 2015 |
Affymetrix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 28, 2015 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organization) (Co |
|
| October 28, 2015 |
Affymetrix 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employe |
|
| October 28, 2015 |
AFFYMETRIX REPORTS THIRD QUARTER 2015 OPERATING RESULTS EX-99.1 2 affx-20150930ex99x1.htm EXHIBIT 99.1 EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS THIRD QUARTER 2015 OPERATING RESULTS Santa Clara, Calif.—October 28, 2015—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2015. Results for the three months ended September 30, 2015: • Total revenue was |
|
| July 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, IN |
|
| July 29, 2015 |
Affymetrix 8-K (Current Report/Significant Event) AFFX-2015.06.30-PR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) |
|
| July 29, 2015 |
AFFYMETRIX REPORTS SECOND QUARTER 2015 OPERATING RESULTS AFFX-2015.06.30 ex99-1 EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS SECOND QUARTER 2015 OPERATING RESULTS Santa Clara, Calif. ? July 29, 2015 ?Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2015 . Results for the three months ended June 30, 2015 : ? Reported revenue growth of 4.1% and 7.9% o |
|
| May 29, 2015 |
AFFX-2014-Form SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT Affymetrix, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 3420 Central Expressway, Santa Clara, CA 95051 (Address of Principa |
|
| May 29, 2015 |
Affymetrix, Inc. Conflict Minerals Report For the Year Ended December 31, 2014 AFFX-2014-Exhibit 1.01 EXHIBIT 1.01 Affymetrix, Inc. Conflict Minerals Report For the Year Ended December 31, 2014 Introduction This report for the year ended December 31, 2014 has been prepared and is presented to comply with Section 13(p) of the Securities Exchange Act of 1934 and Rule 13p-1 (the Rule) and Form SD thereunder. The Rule was adopted by the Securities and Exchange Commission (SEC) t |
|
| May 18, 2015 |
Exhibit 99.1 AFFYMETRIX, INC. AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN (AS AMENDED THROUGH MAY 13, 2015) TABLE OF CONTENTS Page ARTICLE 1. INTRODUCTION 1 ARTICLE 2. ADMINISTRATION 1 2.1. Committee Composition 1 2.2. Committee Responsibilities 1 2.3. Committee for Non-Officer Grants 1 2.4. Nontransferability 2 ARTICLE 3. SHARES AVAILABLE FOR GRANTS 2 3.1. Basic Limitation 2 3.2. Additional S |
|
| May 18, 2015 |
As filed with the Securities and Exchange Commission on May 18, 2015 Registration No. |
|
| May 15, 2015 |
Unassociated Document POWER OF ATTORNEY Know all persons by these presents, that the undersigned hereby constitutes and appoints each of Siang H. |
|
| May 15, 2015 |
Press Release Affymetrix acquires assets of Eureka Genomics Corporation to provide high throughput and economical crop and animal genotyping Santa Clara, CA, May 14, 2015 ? Affymetrix (NASDAQ: AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics? Corporation for $15 million in an all cash transaction. |
|
| May 15, 2015 |
Affymetrix FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Identi |
|
| April 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, I |
|
| April 29, 2015 |
Affymetrix 8-K (Current Report/Significant Event) AFFX-2015.03.31-PR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) |
|
| April 29, 2015 |
AFFYMETRIX REPORTS FIRST QUARTER 2015 OPERATING RESULTS AFFX-2015.03.31 ex99-1 EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FIRST QUARTER 2015 OPERATING RESULTS Santa Clara, Calif. ? April 29, 2015 ?Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the first quarter of 2015 . Results for the three months ended March 31, 2015 : ? Reported revenue growth of 6.9% and 9.1% o |
|
| March 31, 2015 |
Affymetrix NOTICE & ACCESS DEFA14A 1 d896033ddefa14a.htm NOTICE & ACCESS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission O |
|
| March 31, 2015 |
Affymetrix DEFINITIVE PROXY STATEMENT DEF 14A 1 d889845ddef14a.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Co |
|
| February 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) 001-13111 (Commission File Number) California 77-0319159 (State or other jurisdiction of (I.R |
|
| February 18, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 affx1231201410-k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE |
|
| February 18, 2015 |
AFFYMETRIX, INC. LIST OF SUBSIDIARIES EXHIBIT 21 AFFYMETRIX, INC. LIST OF SUBSIDIARIES Affymetrix Biotech Ltda., a wholly-owned subsidiary incorporated in Brazil and doing business under such name. Affymetrix Biotech Shanghai Ltd., a wholly-owned subsidiary incorporated in China and doing business under such name. Affymetrix Japan K.K., a wholly-owned subsidiary incorporated in Japan and doing business under such name. Affymetrix Pte |
|
| February 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 17, 2015 |
AFFX / Affymetrix, Inc. / ORBIMED ADVISORS LLC - SCHEDULE 13G AMENDMENT FILING Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 17, 2015 |
AFFX / Affymetrix, Inc. / CITADEL ADVISORS LLC - SC 13G/A Passive Investment SC 13G/A 1 v399231sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Affymetrix, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2 |
|
| February 13, 2015 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D. |
|
| February 10, 2015 |
AFFX / Affymetrix, Inc. / VANGUARD GROUP INC Passive Investment affymetrixinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: Affymetrix Inc Title of Class of Securities: Common Stock CUSIP Number: 00826T108 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to desi |
|
| February 5, 2015 |
AFFX / Affymetrix, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 4, 2015 |
AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS Santa Clara, Calif.—February 4, 2015—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2014. Results for the year ended December 31, 2014: • Total revenue was $349.0 million, as com |
|
| February 4, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Id |
|
| January 30, 2015 |
8-K 1 affx-201501308xk.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) 001-13111 (Commission File Number) California 77-0319159 (State |
|
| January 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2015 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) California 001-13111 77-0319159 (State or other jurisdiction of incorporation) (Commission Fil |
|
| January 12, 2015 |
EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors Santa Clara, Calif.—January 12, 2015 —Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary, unaudited financial data, the Company expects t |
|
| November 19, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 d823137d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in charter) Delaware 0-28218 77-0319159 (State of incorporation) (Commission Fi |
|
| November 19, 2014 |
Prepared by R.R. Donnelley Financial - Prospectus Supplement Filed Pursuant to Rule 424(b)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-181781 Prospectus Supplement (To Prospectus dated June 14, 2012) $50,000,000 Common Stock We have entered into a sales agreement with Cantor Fitzgerald & Co. relating to shares of our common stock offered by this prospectus supplement |
|
| November 19, 2014 |
EX-1.1 2 d823137dex11.htm EX-1.1 Exhibit 1.1 AFFYMETRIX, INC. Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement November 18, 2014 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: Affymetrix, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), |
|
| October 30, 2014 |
ADDENDUM 26101 Miles Road, Warrensville Heights, Ohio 44128 ADDENDUM 26101 Miles Road, Warrensville Heights, Ohio 44128 THIS AGREEMENT OF LEASE EXTENSION, made as of this 26th day of August, 2014, by and between Miles Commerce Ltd. |
|
| October 30, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 affy-20140930xpr.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commissio |
|
| October 30, 2014 |
AFFYMETRIX REPORTS THIRD QUARTER 2014 OPERATING RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS THIRD QUARTER 2014 OPERATING RESULTS Santa Clara, Calif.—October 30, 2014—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2014. Results for the three months ended September 30, 2014: • Total revenue was $87.1 million, compared to $80.4 million in th |
|
| October 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 affx-20140930x10q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COM |
|
| October 30, 2014 |
ADDENDUM 26111 Miles Road, Warrensville Heights, Ohio 44128 ADDENDUM 26111 Miles Road, Warrensville Heights, Ohio 44128 THIS AGREEMENT OF LEASE EXTENSION, made as of this 26th day of August, 2014, by and between 26111 Miles Road Ltd. |
|
| August 4, 2014 |
LIMITED WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT LIMITED WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT THIS LIMITED WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of July 28, 2014, by and among AFFYMETRIX, INC. |
|
| August 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, IN |
|
| July 31, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Ident |
|
| July 31, 2014 |
AFFYMETRIX REPORTS SECOND QUARTER 2014 OPERATING RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS SECOND QUARTER 2014 OPERATING RESULTS Santa Clara, Calif.—July 31, 2014—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2014. Results for the three months ended June 30, 2014: • Total revenue was $85.4 million, compared to $79.5 million in second q |
|
| June 25, 2014 |
Exhibit 10.55 LEASE by and between BMR-10240 SCIENCE CENTER DRIVE LP, a Delaware limited partnership and AFFYMETRIX, INC., a Delaware corporation SMRH:418641349.9 0100-922173 LEASE THIS LEASE (this “Lease”) is entered into as of this 20th day of June, 2014 (the “Execution Date”), by and between BMR-10240 SCIENCE CENTER DRIVE LP, a Delaware limited partnership (“Landlord”), and AFFYMETRIX, INC., a |
|
| June 25, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) 001-13111 (Commission File Number) California 77-0319159 (State or other jurisdiction of (I.R.S. |
|
| June 25, 2014 |
Exhibit 10.54 LEASE by and between BMR-10255 SCIENCE CENTER LP, a Delaware limited partnership and AFFYMETRIX, INC., a Delaware corporation SMRH:418641422.8 0100-922173 LEASE THIS LEASE (this “Lease”) is entered into as of this 20th day of June, 2014 (the “Execution Date”), by and between BMR-10255 SCIENCE CENTER LP, a Delaware limited partnership (“Landlord”), and AFFYMETRIX, INC., a Delaware cor |
|
| June 5, 2014 |
Other Events, Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Identi |
|
| May 12, 2014 |
OMB APPROVAL OMB Number: 3235-0697 Expires: May 31, 2016 May 31, 2016 Estimated average burden hours per response. |
|
| May 12, 2014 |
Affymetrix, Inc. Conflict Minerals Report For The Year Ended December 31, 2013 Exhibit 1.01 Affymetrix, Inc. Conflict Minerals Report For The Year Ended December 31, 2013 This report for the year ended December 31, 2013 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the Rule). For the purpose of the required Reasonable Country of Origin Inquiry (RCOI), Affymetrix continued to receive supply chain responses through March 10, 2014. The Rule w |
|
| May 5, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, I |
|
| May 1, 2014 |
AFFYMETRIX REPORTS FIRST QUARTER 2014 OPERATING RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FIRST QUARTER 2014 OPERATING RESULTS Santa Clara, Calif.—May 1, 2014—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the first quarter of 2014. Results for the three months ended March 31, 2014: • Total revenue was $83.0 million, compared to $77.9 million in first quart |
|
| May 1, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Identif |
|
| April 23, 2014 |
Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 23, 2014 |
- DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 3, 2014 |
AFFYMETRIX, INC. LIST OF SUBSIDIARIES EXHIBIT 21 AFFYMETRIX, INC. LIST OF SUBSIDIARIES Affymetrix Biotech Ltda., a wholly-owned subsidiary incorporated in Brazil and doing business under such name. Affymetrix Biotech Shanghai Ltd., a wholly-owned subsidiary incorporated in China and doing business under such name. Affymetrix France S.A.S., a wholly-owned subsidiary incorporated in France and doing business under such name. Affymetrix |
|
| March 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 affx1231201310-k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Affymetrix, Inc. |
|
| February 14, 2014 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Affymetrix, Inc (Name of Issuer) Common (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2013 (Date of Event W |
|
| February 13, 2014 |
AFFX / Affymetrix, Inc. / ORBIMED ADVISORS LLC - SCHEDULE 13G AMENDMENT FILING Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2014 |
AFFX / Affymetrix, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 10, 2014 |
AFFX / Affymetrix, Inc. / VANGUARD GROUP INC Passive Investment affymetrixinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Affymetrix Inc Title of Class of Securities: Common Stock CUSIP Number: 00826T108 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to desi |
|
| February 7, 2014 |
AFFX / Affymetrix, Inc. / APG Group - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 7, 2014 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. EX-99.16 POA 2 misc1.htm MISCELLANEOUS EXHIBITS POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration |
|
| February 7, 2014 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration number 14099617 (the “Grantor). Whereas: (a) th |
|
| February 7, 2014 |
AFFX / Affymetrix, Inc. / APG Asset Management US Inc. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 5, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Id |
|
| February 5, 2014 |
AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2013 RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2013 RESULTS Santa Clara, Calif.—February 5, 2014—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2013. Results for the three months ended December 31, 2013: • Total revenue was $92.6 million, |
|
| January 17, 2014 |
AFFX / Affymetrix, Inc. / CITADEL ADVISORS LLC - SC 13G Passive Investment SC 13G 1 v365580sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Affymetrix, Inc. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 00826T108 (CUSIP Number) January 9, 2014 Date |
|
| January 17, 2014 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Common Stock of Affymetrix, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersig |
|
| January 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: January 9, 2014 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| January 7, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2014 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Ide |
|
| January 7, 2014 |
- Affymetrix Announces Preliminary Fourth Quarter 2013 Revenue of Approximately $91 Million - EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 - Affymetrix Announces Preliminary Fourth Quarter 2013 Revenue of Approximately $91 Million - Santa Clara, Calif.-January 7, 2014 -Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary, unaudited financial data, the Company expects total revenue for the fourth quarter of 2013 will be approxima |
|
| November 7, 2013 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment OMB APPROVAL UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009 Washington, D. |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRI |
|
| October 30, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Id |
|
| October 30, 2013 |
AFFYMETRIX REPORTS THIRD QUARTER 2013 OPERATING RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS THIRD QUARTER 2013 OPERATING RESULTS Santa Clara, Calif.—October 30, 2013—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2013. Results for the three months ended September 30, 2013: • Total revenue was $80.4 million, which included revenue from eBi |
|
| October 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: October 17, 2013 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| October 21, 2013 |
FOURTH AMENDMENT TO CREDIT AGREEMENT Exhibit 10.51 FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of October 17, 2013, by and among AFFYMETRIX, INC., a Delaware corporation (the “Borrower”), the other Credit Parties signatory hereto, GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, “GE Capital”), for itself and as agent for |
|
| September 11, 2013 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment OMB APPROVAL UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009 Washington, D. |
|
| August 6, 2013 |
May 20, 2013 Dear Gavin: It is our pleasure to offer you the position of Chief Financial Officer and Executive Vice President with Affymetrix, reporting to Frank Witney, Chief Executive Officer. |
|
| August 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, IN |
|
| August 6, 2013 |
June 28, 2013 Timothy Barabe 1855 Jones Street San Francisco, CA 94109 Re: Separation Agreement Dear Tim: This letter, upon your signature, will constitute the Separation Agreement (this ?Agreement?) between you and Affymetrix, Inc. |
|
| July 31, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Ident |
|
| July 31, 2013 |
AFFYMETRIX REPORTS SECOND QUARTER 2013 OPERATING RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS SECOND QUARTER 2013 OPERATING RESULTS Santa Clara, Calif.—July 31, 2013—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2013. Results for the three months ended June 30, 2013: • Total revenue was $79.5 million, which included revenue from eBioscien |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: May 20, 2013 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| May 10, 2013 |
Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employe |
|
| May 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1 to Form 10-Q) (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSI |
|
| May 1, 2013 |
EXHIBIT 10.49 March 29, 2013 John Runkel 640 W. Santa Inez Hillsborough, CA 94010 Re: Separation Agreement Dear John: This letter, upon your signature, will constitute the Separation Agreement (this "Agreement") between you and Affymetrix, Inc. ("Affymetrix"), on the terms of your separation from employment with Affymetrix. 1. Termination Date. This is to inform you that your employment is termina |
|
| May 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, I |
|
| May 1, 2013 |
EXHIBIT 10.47 December 2, 2011 David Weber 110 El Granada Blvd. El Granada, CA 94018 Dear David, It is our pleasure to offer you the position of Senior Vice President, Global Commercial Operations with Affymetrix. We are excited about the experience and potential you bring to our company. You will report directly to Frank Witney, and be based in the Santa Clara, CA office. You will be classified a |
|
| May 1, 2013 |
THIRD AMENDMENT AND LIMITED WAIVER TO CREDIT AGREEMENT EXHIBIT 10.50 THIRD AMENDMENT AND LIMITED WAIVER TO CREDIT AGREEMENT THIS THIRD AMENDMENT AND LIMITED WAIVER TO CREDIT AGREEMENT (this "Agreement") is entered into as of April 8, 2013, by and among AFFYMETRIX, INC., a Delaware corporation (the "Borrower"), the other Credit Parties signatory hereto, GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, "GE Capita |
|
| May 1, 2013 |
EXHIBIT 10.48 CONSULTING AGREEMENT John F. Runkel, Jr. ("Consultant"), with offices at 640 W. Santa Inez Avenue, Hillsborough, CA 94010 and Affymetrix, Inc. ("Affymetrix"), a Delaware corporation whose principal office is located at 3420 Central Expressway, Santa Clara, CA 95051, enter into the following agreement ("Agreement"). 1. Work Scope. Consultant shall provide consulting services based on |
|
| April 30, 2013 |
AFFYMETRIX REPORTS 2013 FIRST QUARTER RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS 2013 FIRST QUARTER RESULTS Santa Clara, Calif.—April 30, 2013—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three months ended March 31, 2013. Results for the three months ended March 31, 2013: · Total revenue was $77.9 million, which included revenue from eBiosci |
|
| April 30, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Iden |
|
| April 9, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: April 9, 2013 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| April 9, 2013 |
Affymetrix Announces Preliminary Revenue for First Quarter 2013 EX-99.1 2 ex99-1.htm EX-99.1 EXHIBIT 99.1 Investor Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 Affymetrix Announces Preliminary Revenue for First Quarter 2013 Santa Clara, Calif., April 9, 2013 - Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of |
|
| March 27, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 27, 2013 |
DEFA14A 1 d492015ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| March 22, 2013 |
EX-99.1 2 ex99-1.htm EX-99.1 EXHIBIT 99.1 Press Release Affymetrix signs contract with UK Biobank to genotype 500,000 UK individuals in the largest ever study of genetic and environmental factors in disease and personalized medicine. Santa Clara, Calif., March 22, 2013 – Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has signed a contract with UK Biobank to genotype 500,000 DNA samples do |
|
| March 22, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Iden |
|
| March 4, 2013 |
AFFYMETRIX, INC. PERFORMANCE BASED RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT EXHIBIT 10.10 AFFYMETRIX, INC. PERFORMANCE BASED RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT [Name] Award Number: [Award Number] [Address] ID: [Employee Identifier] Plan: Affymetrix, Inc. Amended and Restated 2000 Equity Incentive Plan (the "Plan) 1. Grant of Performance Based Restricted Stock Units. AFFYMETRIX, INC., a Delaware corporation (the "Company") hereby grants to [Name] ("Recipient" |
|
| March 4, 2013 |
AFFYMETRIX, INC. NON-QUALIFIED STOCK OPTION GRANT NOTICE AND AGREEMENT EXHIBIT 10.7 AFFYMETRIX, INC. NON-QUALIFIED STOCK OPTION GRANT NOTICE AND AGREEMENT [Name] Option Number: [Option Number] [Address] ID: [Employee Identifier] Plan: Affymetrix, Inc. Amended and Restated 2000 Equity Incentive Plan (the "Plan") 1. Grant of Option. AFFYMETRIX, INC., a Delaware corporation (the "Company") hereby grants to [Name] ("Optionee") a Non-Qualified Stock Option (the "Option") |
|
| March 4, 2013 |
EXHIBIT 10.30 SUBLEASE AGREEMENT 1. PARTIES This Sublease Agreement (the "Sublease") is entered into as of the 11th day of January, 2013 by and between STMICROELECTRONICS, INC., a Delaware corporation with principal place of business at 750 Canyon Drive, Coppell, Texas 75019 ("Sublessor"), and EBIOSCIENCE, INC., a California corporation with its principal place of business at 10255 Science Center |
|
| March 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 0-28218 AFFYMETRIX, INC. |
|
| March 4, 2013 |
EXHIBIT 10.31 OFFICE LEASE KILROY REALTY KILROY UNIVERSITY CENTER KILROY REALTY, L.P., a Delaware limited partnership, as Landlord, and EBIOSCIENCE, INC., a California corporation, as Tenant. KILROY REALTY 703150.05/3VLA Kilroy University Center 888888-00775/ I -8- I 3//eg [EBioseienee, Inc.] TABLE OF CONTENTS Page ARTICLE 1 PREMISES, BUILDING, PROJECT, AND COMMON AREAS 1 ARTICLE 2 LEASE TERM; OPT |
|
| March 4, 2013 |
SECOND AMENDMENT TO CREDIT AGREEMENT EXHIBIT 10.46 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this "Agreement") is entered into as of December 5, 2012, by and among AFFYMETRIX, INC., a Delaware corporation (the "Borrower"), the other Credit Parties signatory hereto, GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, "GE Capital"), for itself and as agent for |
|
| March 4, 2013 |
AFFYMETRIX, INC. LIST OF SUBSIDIARIES EXHIBIT 21 AFFYMETRIX, INC. LIST OF SUBSIDIARIES Affymetrix Biotech Ltda., a wholly-owned subsidiary incorporated in Brazil and doing business under such name. Affymetrix Biotech Shanghai Ltd., a wholly-owned subsidiary incorporated in China and doing business under such name. Affymetrix France S.A.S., a wholly-owned subsidiary incorporated in France and doing business under such name. Affymetrix |
|
| March 4, 2013 |
EXHIBIT 10.33 In this translation an attempt has been made to be as literal as possible without jeopardizing the overall continuity. Inevitably, differences may occur in translation, and if so, the original German text will govern. VIENNA Standortmanagement GmbH Rotenturmstraße 17/3/17, A-1010 Wien T: +43/ 1/ 532,36,03, F: +4311/532 9503-9 [email protected] Firma Bender Medsystems Diagnostics GmbH Ren |
|
| March 4, 2013 |
EXHIBIT 10.32 SUBLEASE AGREEMENT between LIGAND PHARMACEUTICALS INCORPORATED as Sublandlord and eBIOSCIENCE, INC. as Subtenant Building Address: 10255 Science Center Drive San Diego, California 92121 SUBLEASE AGREEMENT THIS SUBLEASE AGREEMENT ("Sublease") is made as of December 6, 2007, by and between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation ("Sublandlord") and eBIOSCIENCE, INC. |
|
| March 4, 2013 |
AFFYMETRIX, INC. RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT EXHIBIT 10.8 AFFYMETRIX, INC. RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT [Name] Award Number: [Award Number] [Address] ID: [Employee Identifier] Plan: Affymetrix, Inc. Amended and Restated 2000 Equity Incentive Plan (the "Plan) 1. Grant of Restricted Stock Units. AFFYMETRIX, INC., a Delaware corporation (the "Company") hereby grants to [Name] ("Recipient") the number of restricted stock unit |
|
| March 4, 2013 |
FIRST AMENDMENT TO CREDIT AGREEMENT EXHIBIT 10.45 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this "Agreement") is entered into as of July 20, 2012, by and among AFFYMETRIX, INC., a Delaware corporation (the "Borrower"), the other Credit Parties signatory hereto, GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, "GE Capital"), for itself and as agent for the L |
|
| February 22, 2013 |
AFFX / Affymetrix, Inc. / VANGUARD GROUP INC Passive Investment affymetrixinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Affymetrix Inc Title of Class of Securities: Common Stock CUSIP Number: 00826T108 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to desi |
|
| February 20, 2013 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration number 14099617 (the “Grantor). Whereas: (a) th |
|
| February 20, 2013 |
AFFX / Affymetrix, Inc. / APG Group - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| February 14, 2013 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . . 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Affymetrix Inc. (Name of Issuer) Common (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2012 (Date of Event |
|
| February 12, 2013 |
AFFX / Affymetrix, Inc. / APG Group - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| February 12, 2013 |
AFFX / Affymetrix, Inc. / APG Asset Management US Inc. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| February 12, 2013 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. EX-99.16 POA 2 misc1.htm MISCELLANEOUS EXHIBITS POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration |
|
| February 12, 2013 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration number 14099617 (the “Grantor). Whereas: (a) th |
|
| February 11, 2013 |
AFFX / Affymetrix, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 11, 2013 |
AFFX / Affymetrix, Inc. / VANGUARD GROUP INC Passive Investment affymetrixinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Affymetrix Inc Title of Class of Securities: Common Stock CUSIP Number: 00826T108 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to desi |
|
| February 6, 2013 |
AFFX / Affymetrix, Inc. / WHV Investments, Inc. - SCHEDULE 13G AMENDMENT FILING Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 31, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2013 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Id |
|
| January 31, 2013 |
AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2012 RESULTS EX-99.1 2 ex99-1.htm EX-99.1 EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2012 RESULTS Santa Clara, Calif.—January 31, 2013—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2012. Results for the three months ended December 31, 2012: · Tot |
|
| January 9, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: January 8, 2013 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| January 9, 2013 |
EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 Affymetrix Announces Preliminary Fourth Quarter Revenue of $84 Million and Implements Corporate Restructuring to Accelerate Path to Profitability · Preliminary fourth quarter revenue of $84 million. · Restructuring expected to result in savings of approximately $25 million on an annualized basis · The Company prep |
|
| January 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: January 8, 2013 (Date of earliest event reported) AFFYMETRIX, INC. |
|
| November 27, 2012 |
AFFX / Affymetrix, Inc. / APG Asset Management US Inc. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826T108 (CUSIP Number) November 15, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| November 27, 2012 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. EX-99.16 2 misc1.htm MISCELLANEOUS EXHIBITS POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration num |
|
| November 21, 2012 |
POWER OF ATTORNEY APG Algemene Pensioen Groep NV. POWER OF ATTORNEY APG Algemene Pensioen Groep NV. APG Algemene Pensioen Groep N.V., a public company (naamloze vennootschap), having its seat (statutaire zetel) in Heerlen, the Netherlands and its registered place of business at Oude Lindestraat 70, 6411 EJ Heerlen, the Netherlands, registered with the Chamber of Commerce of Limburg with registration number 14099617 (the “Grantor). Whereas: (a) th |
|
| November 21, 2012 |
AFFY / Affymax, Inc. / APG Asset Management US Inc. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* AFFYMETRIX INC (Name of Issuer) Common Stock (Title of Class of Securities) 00826A109 (CUSIP Number) November 15, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| November 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRI |
|
| November 5, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2012 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Id |
|
| November 5, 2012 |
AFFYMETRIX REPORTS THIRD QUARTER 2012 RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS THIRD QUARTER 2012 RESULTS Santa Clara, Calif.—November 5, 2012—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from eBioscience during the third |
|
| October 9, 2012 |
Affymetrix Announces Preliminary Revenue for Third Quarter 2012 EXHIBIT 99.1 Investor Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 Affymetrix Announces Preliminary Revenue for Third Quarter 2012 Santa Clara, Calif., October 8, 2012 - Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of appr |
|
| October 9, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2012 AFFYMETRIX, INC. (Exact name of registrant as specified in its charter) DELAWARE 0-28218 77-0319159 (State of incorporation) (Commission File Number) (IRS Employer Ide |
|
| August 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0- |
|
| August 9, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . COMMISSION FILE NO. 0-28218 AFFYMETRIX, IN |
|
| August 9, 2012 |
EXECUTIVE SEVERANCE POLICY (Amended as of May 11, 2012) EXHIBIT 10.37 EXECUTIVE SEVERANCE POLICY (Amended as of May 11, 2012) I. PURPOSE AND ELIGIBILITY Affymetrix Inc. (the "Company") has adopted this Executive Severance Policy ("Policy") to provide guidelines for the granting of severance pay and/or certain other benefits (as set forth in Section III.B below, "Severance Pay") under specified circumstances to certain officers of the Company who (i) a |
|
| July 31, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 31, 2012 |
AFFYMETRIX REPORTS SECOND QUARTER 2012 RESULTS EXHIBIT 99.1 Contact: Doug Farrell Vice President of Investor Relations 408-731-5285 AFFYMETRIX REPORTS SECOND QUARTER 2012 RESULTS Santa Clara, Calif.-July 31, 2012-Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue from eBioscience following the clos |
|
| June 29, 2012 |
Affymetrix, Inc. 2012 Inducement Plan Exhibit 99.1 Affymetrix, Inc. 2012 Inducement Plan ARTICLE 1. INTRODUCTION. The Plan is designed to attract new Employees (including new hires from acquired entities) and is intended to satisfy the requirements of Nasdaq Marketplace Rule 4350. The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by encouraging the attraction of Employees |
|
| June 29, 2012 |
As filed with the Securities and Exchange Commission on June 29, 2012 Registration No. |
|
| June 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 25, 2012 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organization) (Commi |
|
| June 25, 2012 |
Credit Agreement Exhibit 10.1 L&W Draft 6/20/212 $100,000,000 CREDIT FACILITY CREDIT AGREEMENT Dated as of June 25, 2012 by and among AFFYMETRIX, INC., as the Borrower, THE OTHER PERSONS PARTY HERETO THAT ARE DESIGNATED AS CREDIT PARTIES, GENERAL ELECTRIC CAPITAL CORPORATION, as Agent, and THE OTHER FINANCIAL INSTITUTIONS PARTY HERETO, as Lenders, *************************** SILICON VALLEY BANK, a |
|
| June 25, 2012 |
First Supplemental Indenture Exhibit 4.2 AFFYMETRIX, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee First Supplemental Indenture Dated as of June 25, 2012 to Indenture Dated as of June 25, 2012 4.00% Convertible Senior Notes due 2019 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. References to Interest 8 ARTICLE 2 ISSUE, DESCRIPTION, EX |
|
| June 25, 2012 |
Exhibit 4.1 AFFYMETRIX, INC., Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., Trustee INDENTURE Dated as of June 25, 2012 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Construction 1 ARTICLE 2 SECURITIES Section 2.01. Forms Generally 6 Section 2.02. Form of Trustee’s Certification of Authentication 7 Section 2.03. Amou |
|
| June 21, 2012 |
4.00% CONVERTIBLE SENIOR NOTES DUE 2019 Interest payable on July 1 and January 1 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-181781 Prospectus Supplement (To Prospectus dated June 14, 2012) $105,000,000 4.00% CONVERTIBLE SENIOR NOTES DUE 2019 Interest payable on July 1 and January 1 We are offering $105,000,000 principal amount of our 4.00% Convertible Senior Notes due 2019 (the “notes”). The notes will bear interest at a rate of 4.00% per year, pay |
|
| June 20, 2012 |
AFFYMETRIX, INC. 4.00% Convertible Senior Notes due 2019 Underwriting Agreement Underwriting Agreement Exhibit 99.1 EXECUTION COPY AFFYMETRIX, INC. $105,000,000 4.00% Convertible Senior Notes due 2019 Underwriting Agreement June 19, 2012 Citigroup Global Markets Inc. 388 Greenwich Street New York, NY 10013 Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 As Representatives of the several Underwriters Ladies and Gentlemen: Affymetrix, Inc., a Delaware corporation (the |
|
| June 20, 2012 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 19, 2012 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 0-28218 77-0319159 (State or Other Jurisdiction of Incorporation or Organization) (Commi |
|
| June 20, 2012 |
Affymetrix, Inc. $105,000,000 aggregate principal amount of 4.00% Convertible Senior Notes due 2019 FWP 1 d357419dfwp.htm FWP Filed Pursuant to Rule 433 Registration No. 333-181781 Pricing Term Sheet June 19, 2012 Affymetrix, Inc. $105,000,000 aggregate principal amount of 4.00% Convertible Senior Notes due 2019 The information in this pricing term sheet relates to Affymetrix, Inc.’s offering (the “Offering”) of its 4.00% Convertible Senior Notes due 2019 and should be read together with the pre |
|
| June 18, 2012 |
Subject to completion, dated June 18, 2012 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-181781 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. A registration statement relating to the notes has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement is not an offer to sell the notes and it i |
|
| June 8, 2012 |
AFFX / Affymetrix, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G Passive Investment OMB APPROVAL UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009 Washington, D. |
|
| June 1, 2012 |
Amendment no. 1 to Form S-3 Table of Contents As filed with the Securities and Exchange Commission on May 31, 2012 Registration No. 333-181781 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AFFYMETRIX, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 77-0319159 (State or Other Jurisdi |
|
| May 31, 2012 |
Statement regarding computation of Consolidated Ratio of Earnings Exhibit 12.1 Affymetrix, Inc. Computation of Ratio of Earnings to Fixed Charges and Preferred Stock Dividends (in thousands) Our earnings were insufficient to cover fixed charges for the three-month period ended March 31, 2012 and in each of the years in the five-year period ended December 31, 2011, with the exception of the year en |
|
| May 31, 2012 |
Exhibit 25.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its charter) 95- |
|
| May 31, 2012 |
Report of Independent Auditors Exhibit 99.1 Report of Independent Auditors To the Board of Directors eBioscience Holding Company, Inc. We have audited the consolidated balance sheets of eBioscience Holding Company, Inc. as of December 31, 2010 and 2011, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2011. |
|
| May 31, 2012 |
Form S-3 Table of Contents As filed with the Securities and Exchange Commission on May 30, 2012 Registration No. |
|
| May 31, 2012 |
AFFYMETRIX, INC. UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Unaudited Proforma Condensed Combined Consolidated Financial Statements Exhibit 99. |
|
| May 31, 2012 |
Form of Senior Indenture Exhibit 4.3 [FORM OF SENIOR INDENTURE] AFFYMETRIX, INC., Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., Trustee INDENTURE Dated as of [—], 2012 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Construction 1 ARTICLE 2 SECURITIES Section 2.01. Forms Generally 6 Section 2.02. Form of Trustee’s Cert |
